eComment. The vraisemblance of haemostatic therapy for excessive bleeding after cardiac surgery
- PMID: 22908177
- PMCID: PMC3422974
- DOI: 10.1093/icvts/ivs307
eComment. The vraisemblance of haemostatic therapy for excessive bleeding after cardiac surgery
Comment on
-
Use of prothrombin complex concentrate for excessive bleeding after cardiac surgery.Interact Cardiovasc Thorac Surg. 2012 Sep;15(3):382-9. doi: 10.1093/icvts/ivs224. Epub 2012 May 23. Interact Cardiovasc Thorac Surg. 2012. PMID: 22623627 Free PMC article.
References
-
- Ekert H, Brizard C, Eyers R, Cochrane A, Henning R. Elective administration in infants of low-dose recombinant activated factor VII (rFVIIa) in cardiopulmonary bypass surgery for congenital heart disease does not shorten time to chest closure or reduce blood loss and need for transfusions: a randomized, double-blind, parallel group, placebo-controlled study of rFVIIa and standard haemostatic replacement therapy versus standard haemostatic replacement therapy. Blood Coagul Fibrinolysis 2006;5:389–95 - PubMed
-
- Kylasam S, Mos K, Fijtin S, Webster B, Chard R, Egan J. Recombinant activated factor VII following pediatric cardiac surgery. J Intensive Care Med 2009;2:116–21 - PubMed
-
- Pychynska-Pokorska M, Moll JJ, Krajewski W, Jarosik The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. Pediatr Crit Care Med 2004;3:246–50 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
